Wound healing in glaucoma surgery. Part 1. Wound healing morphology
https://doi.org/10.21516/2072-0076-2024-17-4-116-120
Abstract
Glaucoma is a leading cause of blindness in the world. A proven condition for preventing the progression of glaucomatous optic neuropathy is to reduce intraocular pressure. Therapy begins with local hypotensive drugs; if they are ineffective, laser treatment or surgery is used. However, hypotensive intervention does not guarantee a stable hypotensive effect. Wound healing is a complex physiological dynamic process that is necessary to maintain homeostasis in the body. This process includes three interrelated phases: inflammation, fibroplasia, and remodulation (maturation) of the scar. Thе review presents various cellular mechanisms involved in the regulation of these processes and factors that contribute to excessive scarring. The review presents various cellular mechanisms involved in the regulation of these processes and contributing to excessive scarring. Current knowledge about the key factors of pathomorphological processes occurring in the filtration zone is intended to stimulate the development of new methods for prolonging the effect of filtering surgery.
Supporting agencies: no author has a financial or property interest in any material or method mentioned
About the Authors
N. S. Izmailova
Helmholtz National Medical Research Center of Eye Diseases
Russian Federation
Russian Federation
Natalia S. Izmailova — head of the department of pathological fnatomy and histology, leading researcher, pathologist.
14/19, Sadovaya- Chernogryazskaya St., Moscow, 105062
S. Yu. Petrov
Helmholtz National Medical Research Center of Eye Diseases
Russian Federation
Russian Federation
Sergey Yu. Petrov — Dr. of Med. Sci., head of glaucoma department.
14/19, Sadovaya- Chernogryazskaya St., Moscow, 105062
A. D. Dzebisova
Helmholtz National Medical Research Center of Eye Diseases
Russian Federation
Russian Federation
Angela D. Dzebisova — PhD student, glaucoma department.
14/19, Sadovaya- Chernogryazskaya St., Moscow, 105062
References
1. Tham YC, Li X, Wong TY, et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014; 121 (11): 2081–90. doi:10.1016/j.ophtha.2014.05.013
2. Neroev V.V., Kiseleva O.A., Bessmertny A.M. The main results of a multicenter study of epidemiological features of primary open-angle glaucoma in the Russian Federation. Russian ophthalmological journal. 2013; 6 (3): 4–7 (In Russ.).
3. Quigley H.A., Broman A.T. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006; 90 (3): 262–7. doi:10.1136/bjo.2005.081224
4. Sotimehin AE, Ramulu PY. Measuring disability in glaucoma. J Glaucoma. 2018; 27 (11): 939–9. doi:10.1097/IJG.0000000000001068
5. Saheb H, Ahmed II. Micro-invasive glaucoma surgery: current perspectives and future directions. Curr Opin Ophthalmol. 2012; 23 (2): 96–104. doi:10.1097/ICU.0b013e32834ff1e7
6. Kamenskikh T.G., Veselova E.V., Kolbenev I.O., Petrova Yu.V. Effect of different preservatives on the cornea during instillation of prostaglandin analogues. National journal Glaucoma. 2015; 14 (3): 49–57 (In Russ.).
7. Petrov S.Yu., Vostrukhin S.V., Aslamazova A.E., Sherstneva L.V. Modern methods of minimally invasive glaucoma surgery. Vestnik oftal’mologii. 2016; 132 (3): 96–102 (In Russ.). doi.org/10.17116/oftalma2016132396-102
8. Petrov S.Yu., Safonova D.M. The modern concept of wound healing in glaucoma surgery. Ophthalmology in Russia. 2015; 12 (4): 9–17 (In Russ.). doi.org/10.18008/1816-5095-2015-4-9-17
9. Slonimskiy A.Yu., Alekseyev I.B., Dolgiy S.S. New possibilities of excessive postoperative scarring prophylaxis by glaucoma surgery. Ophthalmology in Russia. 2012; 9 (3): 36–40 (In Russ.).
10. Gurtner G.C., Werner S., Barrandon Y., Longaker M.T. Wound repair and regeneration. Nature. 2008; 453 (7193): 314–321. doi:10.1038/nature07039
11. Anderson RN, Smith BL. Deaths: leading causes for 2001. Natl Vital Stat Rep. 2003 Nov 7; 52 (9): 1–85. PMID: 14626726.
12. Mescher AL, Neff AW. Regenerative capacity and the developing immune system. Adv Biochem Eng Biotechnol. 2005; 93: 39–66. doi:10.1007/b99966
13. Klein L, O'Connor CM, Gattis WA, et al. Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: review of trials and practical considerations. Am J Cardiol. 2003; 91 (9A): 18F-40F. doi:10.1016/s0002-9149(02)03336-2
14. Aarabi S, Longaker MT, Gurtner GC. Hypertrophic scar formation following burns and trauma: new approaches to treatment. PLoS Med. 2007; 4 (9): e234. doi:10.1371/journal.pmed.0040234
15. Levkoeva E.F. Wound process in the eye. USSR AMS. Moscow; 1951 (In Russ.).
16. Chester D, Brown AC. The role of biophysical properties of provisional matrix proteins in wound repair. Matrix Biol. 2017; 60–61: 124–40. doi: 10.1016/j.matbio.2016.08.004
17. Shaarawy TM, Sherwood MB, Hitchings RA, Crowston JG. Glaucoma. Vol. 2: Surgical Management. Second edition. Elsevier; 2015.
18. Abaev Yu.K. Biology of acute and chronic wound healing. Medical news. 2003; 6: 3–10 (In Russ.).
19. Stadelmann WK, Digenis AG, Tobin GR. Impediments to wound healing. Am J Surg. 1998; 176 (2A Suppl): 39S-47S. doi:10.1016/s0002-9610(98)00184-6
20. Clark RA. Potential roles of fibronectin in cutaneous wound repair. Arch Dermatol. 1988 Feb; 124 (2): 201–6. PMID: 3124772.
21. Costa VP, Spaeth GL, Eiferman RA, Orengo-Nania S. Wound healing modulation in glaucoma filtration surgery. Ophthalmic Surg. 1993 Mar; 24 (3): 152–70. PMID: 8483566.
22. Postlethwaite AE, Kang AH. Collagen-and collagen peptide-induced chemotaxis of human blood monocytes. J Exp Med. 1976; 143 (6): 1299–307. doi:10.1084/jem.143.6.1299
23. Leibovich SJ, Ross R. The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum. Am J Pathol. 1975 Jan; 78 (1): 71–100. PMID: 1109560.
24. Barbul A, Regan MC. Immune involvement in wound healing. Otolaryngol Clin North Am. 1995 Oct; 28 (5): 955–68. PMID: 8559582.
25. Leibovich SJ, Ross R. A macrophage-dependent factor that stimulates the proliferation of fibroblasts in vitro. Am J Pathol. 1976 Sep; 84 (3): 501–14. PMID: 961824.
26. Sisto D, Vetrugno M, Trabucco T, et al. The role of antimetabolites in filtration surgery for neovascular glaucoma: intermediate-term follow-up. Acta Ophthalmol Scand. 2007; 85 (3): 267–71. doi:10.1111/j.1600-0420.2006.00810.x
27. Costa VP, Wilson RP, Moster MR, Schmidt CM, Gandham S. Hypotony maculopathy following the use of topical mitomycin C in glaucoma filtration surgery. Ophthalmic Surg. 1993 Jun; 24 (6): 389–94. PMID: 8336889.
28. Zacharia PT, Deppermann SR, Schuman JS. Ocular hypotony after trabeculectomy with mitomycin C. Am J Ophthalmol. 1993; 116 (3): 314–26. doi:10.1016/s0002-9394(14)71349-2
29. Wolner B, Liebmann JM, Sassani JW, et al. Late bleb-related endophthalmitis after trabeculectomy with adjunctive 5-fluorouracil. Ophthalmology. 1991; 98 (7): 1053–60. doi: 10.1016/s0161-6420(91)32177-8
30. Moulin V, Castilloux G, Auger FA, et al. Modulated response to cytokines of human wound healing myofibroblasts compared to dermal fibroblasts. Exp Cell Res. 1998 Jan 10; 238 (1): 283–93. doi: 10.1006/excr.1997.3827
31. Deryugina EI, Bourdon MA, Reisfeld RA, Strongin A. Remodeling of collagen matrix by human tumor cells requires activation and cell surface association of matrix metalloproteinase-2. Cancer Res. 1998 Aug 15; 58 (16): 3743–50. PMID: 9721888.
32. Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell. 1992; 69 (1): 11–25. doi:10.1016/0092-8674(92)90115-s
33. Desjardins DC, Parrish RK, 2nd, Folberg R, et al. Wound healing after filtering surgery in owl monkeys. Arch Ophthalmol. 1986; 104 (12): 1835–9. doi:10.1001/archopht.1986.01050240109050
34. Miller MH, Grierson I, Unger WI, Hitchings RA. Wound healing in an animal model of glaucoma fistulizing surgery in the rabbit. Ophthalmic Surg. 1989 May; 20 (5): 350–7. PMID: 2726151.
35. Desmouliere A, Badid C, Bochaton-Piallat ML, Gabbiani G. Apoptosis during wound healing, fibrocontractive diseases and vascular wall injury. Int J Biochem Cell Biol. 1997; 29 (1): 19–30. doi: 10.1016/s1357-2725(96)00117-3
36. Desmouliere A, Redard M, Darby I, Gabbiani G. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol. 1995 Jan; 146 (1): 56–66. PMID: 7856739.
37. Critchlow MA, Bland YS, Ashhurst DE. The effect of exogenous transforming growth factor-b2 on healing fractures in the rabbit. Bone. 1995; 16 (5): 521–7. doi:10.1016/8756-3282(95)00085-r
38. Tripathi R.C., Li J., Chan W.F., Tripathi B.J. Aqueous humor in glaucomatous eyes contains an increased level of TGF-beta 2. Exp Eye Res. 1994; 59 (6): 723–727. doi:10.1006/exer.1994.1158
39. Brigstock DR. The connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed (CCN) family. Endocr Rev. 1999; 20 (2): 189–206. doi: 10.1210/edrv.20.2.0360
40. Grotendorst GR. Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts. Cytokine Growth Factor Rev. 1997; 8 (3): 171–9. doi: 10.1016/s1359-6101(97)00010-5
41. Li Z, Van Bergen T, Van de Veire S, et al. Inhibition of vascular endothelial growth factor reduces scar formation after glaucoma filtration surgery. Invest Ophthalmol Vis Sci. 2009; 50 (11): 5217–5225. doi: 10.1167/iovs.08-2662
42. Moussad EE, Brigstock DR. Connective tissue growth factor: what's in a name? Mol Genet Metab. 2000; 71 (1–2): 276–92. doi: 10.1006/mgme.2000.3059
43. Wong J, Wang N, Miller JW, Schuman JS. Modulation of human fibroblast activity by selected angiogenesis inhibitors. Exp Eye Res. 1994; 58 (4): 439–51. doi: 10.1006/exer.1994.1037
44. Chua J, Vania M, Cheung CM, et al. Expression profile of inflammatory cytokines in aqueous from glaucomatous eyes. Mol Vis. 2012; 18: 431–8. PMID: 22355254.
45. Erichev V.P., Gankovskaya L.V., Kovalchuk L.V., Gankovskaya O.A., Dugina A.E. Interleukin-17 and its possible participation in reparative processes in glaucoma. Glaucoma. 2009; 1: 23–5 (In Russ.).
46. Malvitte L, Montange T, Vejux A, et al. Measurement of inflammatory cytokines by multicytokine assay in tears of patients with glaucoma topically treated with chronic drugs. Br J Ophthalmol. 2007; 91 (1): 29–32. doi: 10.1136/bjo.2006.101485
Review
For citations:
Izmailova N.S., Petrov S.Yu., Dzebisova A.D. Wound healing in glaucoma surgery. Part 1. Wound healing morphology. Russian Ophthalmological Journal. 2024;17(4):116-120. (In Russ.) https://doi.org/10.21516/2072-0076-2024-17-4-116-120
Views:
321
Email this article 